Oral Contraceptive Pills: Access and Availability
This brief provides an overview of oral contraception, discusses private insurance and Medicaid coverage, and reviews strategies to promote and expand women’s access to oral contraceptives.
View the Latest: Reproductive Health
Filter
-
-
Over-the-Counter Oral Contraceptive Pills
Issue BriefOral contraceptives are the most commonly used method of reversible contraception in the U.S. In July 2023, the FDA approved Opill, the first daily oral contraceptive pill to become available over the counter (OTC) without a doctor’s prescription. This issue brief provides an overview of OTC oral contraceptives and laws and policies related to insurance coverage.
-
Filling in the Gap in Federal Medicaid Funding to Planned Parenthood: State Responses
Policy WatchThis brief examines efforts in 11 states to fill in funding gaps created by the 2025 federal budget reconciliation law, which prohibits federal Medicaid funding for reproductive-health care services provided by Planned Parenthood and other organizations that also provide abortion care.
-
Intrauterine Devices (IUDs): Access and Coverage in the U.S.
Fact SheetIntrauterine devices (IUDs), along with implants, are known as long-acting reversible contraception (LARCs) because they can be used to prevent pregnancy for several years. This fact sheet reviews FDA-approved IUDs, as well as use, availability, and key issues in insurance coverage and financing of IUDs in the U.S.
-
The Mexico City Policy: An Explainer
Issue BriefExplore an overview of the Mexico City Policy and the Promoting Human Flourishing in Foreign Assistance (PHFFA) Policy
-
The Trump Administration’s Latest Expansion of the Mexico City Policy: A Funding Analysis
Issue BriefThis analysis assesses the potential reach of the latest expansion of the Mexico City Policy, which is now part of the Promoting Human Flourishing in Foreign Assistance (PHFFA) Policy.
-
Litigation Challenging the 2025 Budget Reconciliation Law’s Provision Blocking Federal Medicaid Payments to Planned Parenthood
Issue BriefThis brief provides an overview of these legal challenges and summarizes the key positions of the plaintiffs and the defendants, Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS).
-
KFF Health Tracking Poll: Knowledge and Views of Medication Abortion
Poll FindingThis KFF Health Tracking Poll finds that many, including women of reproductive age, remain unfamiliar with key facts about mifepristone. Fewer than half of all adults say they believe abortion pills are safe now, compared to over half of all adults two years ago. This poll explores awareness and perception of the recent FDA review of the medication, and support for policies aimed at restricting it.
-
Policy Landscape of Private Insurance Coverage of Contraception in the U.S.
Issue BriefThis issue brief explains the rules for private insurance coverage of contraceptives at the federal and state level, the exemptions and accommodations available for certain employers, gaps in coverage for contraceptives obtained outside of the traditional clinical setting, and how changes in the agencies responsible for making contraceptive recommendations may affect coverage for contraceptives.
-
Social Media Content Moderation Policies and False Claims that COVID-19 Vaccines Cause Cancer — The Monitor
FeatureThis volume examines recent social media and AI policy changes; conflicting studies on COVID-19 vaccines and cancer; ACOG guidance on contraceptive misinformation; an alternative to the CDC’s MMWR; the Texas AG’s Tylenol lawsuit; and findings from a recent KFF Tracking Poll on trust in health care apps and websites that use AI.